Category Archives: Intestinal Cell

Intestinal Cell News is an online publication and email newsletter that curates the latest research using intestinal cells.
Subscribe
Since 2015, Intestinal Cell News has been a valuable resource for keeping researchers and medical professionals updated on the latest publications, news and events in the field of gastrointestinal cell biology. Our editorial team collects and publishes the most current articles and reviews using stomach, colon, and small and large intestinal cells. We cover topics including the culturing of intestinal cells, intestinal organoids, intestinal cancers, and gastrointestinal conditions such as irritable bowel syndrome and Crohn’s disease.

Twitter Account of Embattled #MeTooSTEM Founder Suspended

Twitter has suspended the account of MeTooSTEM founder BethAnn McLaughlin after allegations emerged that the former Vanderbilt University neuroscientist fabricated the Twitter account of an apparently nonexistent female Native American anthropologist at Arizona State University who had claimed to be an anonymous victim of sexual harassment by a Harvard professor.
[ScienceInsider]
Press Release

Continue reading “Twitter Account of Embattled #MeTooSTEM Founder Suspended”

Bookmark

No account yet? Register

0
Share

Signatures of Co-deregulated Genes and Their Transcriptional Regulators in Colorectal Cancer

Researchers reanalyzed 19 GEO gene expression profiles to identify and annotate colorectal cancer versus normal signatures, single-gene perturbation, and single-drug perturbation signatures.
[npj Systems Biology and Applications]
Full Article

Continue reading “Signatures of Co-deregulated Genes and Their Transcriptional Regulators in Colorectal Cancer”

Bookmark

No account yet? Register

0
Share

ORTIKOS™, the First and Only Once-Daily Dose for Treatment of Mild to Moderate Crohn’s Disease, Now Available in the U.S.

Ferring Pharmaceuticals Inc. announced the launch of ORTIKOS™ in the United States, which was approved as the only once-daily treatment of mild to moderate active Crohn’s disease involving the ileum and/or the ascending colon, in patients 8 years of age and older, and maintenance of clinical remission in adults involving the ileum and/or the ascending colon for up to three months.
[Ferring Pharmaceuticals (Businesswire, Inc.)]
Press Release

Continue reading “ORTIKOS™, the First and Only Once-Daily Dose for Treatment of Mild to Moderate Crohn’s Disease, Now Available in the U.S.”

Bookmark

No account yet? Register

0
Share

The HIF Target ATG9A is Essential for Epithelial Barrier Function and Tight Junction Biogenesis

Investigators found that lentiviral-mediated knockdown of ATG9A in intestinal epithelial cells prevented epithelial barrier formation by >95% and resulted in significant mislocalization of multiple tight junction proteins.
[Molecular Biology of the Cell]
Abstract

Continue reading “The HIF Target ATG9A is Essential for Epithelial Barrier Function and Tight Junction Biogenesis”

Bookmark

No account yet? Register

0
Share

Ciclopirox Activates PERK-Dependent Endoplasmic Reticulum Stress to Drive Cell Death in Colorectal Cancer

Scientists report that ciclopirox exhibited strong antitumorigenic properties in colorectal cancer by inducing cell cycle arrest, repressing cell migration, and invasion by affecting N-cadherin, Snail, E-cadherin, MMP-2, and MMP-9 expression. Disruption of cellular bioenergetics contributed to ciclopirox-associated inhibition of cell growth, migration, and invasion.
[Cell Death & Disease]
Full Article

Continue reading “Ciclopirox Activates PERK-Dependent Endoplasmic Reticulum Stress to Drive Cell Death in Colorectal Cancer”

Bookmark

No account yet? Register

0
Share

Continuous Formation of Small Clusters with LGR5-Positive Cells Contributes to Tumor Growth in a Colorectal Cancer Xenograft Model

Investigators evaluated the growth of moderate differentiated colorectal cancer from LGR5-positive cells, which was a cancer stem cell marker of colorectal cancer, using xenograft and three-dimensional culture models spatiotemporally.
[Laboratory Investigation]
Abstract

Continue reading “Continuous Formation of Small Clusters with LGR5-Positive Cells Contributes to Tumor Growth in a Colorectal Cancer Xenograft Model”

Bookmark

No account yet? Register

0
Share

Cycling Stem Cells Are Radioresistant and Regenerate the Intestine

The authors demonstrate that the DNA damage-resistant Msi1+ cells are cycling intestinal stem cells that maintain and regenerate the intestinal epithelium.
[Cell Reports]
Full ArticleGraphical Abstract

Continue reading “Cycling Stem Cells Are Radioresistant and Regenerate the Intestine”

Bookmark

No account yet? Register

0
Share

Microbiota-Derived Metabolite Promotes HDAC3 Activity in the Gut

Intestinal exposure to inositol trisphosphate and phytate ingestion both promoted recovery following intestinal damage. Remarkably, inositol trisphosphate also induced growth of patient-derived intestinal organoids, stimulated HDAC3-dependent proliferation, and countered butyrate inhibition of colonic growth.
[Nature]
AbstractPress Release

Continue reading “Microbiota-Derived Metabolite Promotes HDAC3 Activity in the Gut”

Bookmark

No account yet? Register

0
Share

Src Family Tyrosine Kinases in Intestinal Homeostasis, Regeneration and Tumorigenesis

The authors review recent findings on Src family kinase (SFK) signalling during intestinal homeostasis, regeneration and tumorigenesis. They also describe the key nongenetic mechanisms underlying SFK tumour activities in colorectal cancer, and discuss how these mechanisms could be exploited in therapeutic strategies to target SFK signalling in metastatic colon cancer.
[Cancers]
Full Article

Continue reading “Src Family Tyrosine Kinases in Intestinal Homeostasis, Regeneration and Tumorigenesis”

Bookmark

No account yet? Register

0
Share

LINC00941 Promotes CRC Metastasis through Preventing SMAD4 Protein Degradation and Activating the TGF-β/SMAD2/3 Signaling Pathway

LINC00941 was found to activate EMT by directly binding the SMAD4 protein MH2 domain and competing with β-TrCP to prevent SMAD4 protein degradation, thus activating the TGF-β/SMAD2/3 signaling pathway.
[Cell Death & Differentiation]
Abstract

Continue reading “LINC00941 Promotes CRC Metastasis through Preventing SMAD4 Protein Degradation and Activating the TGF-β/SMAD2/3 Signaling Pathway”

Bookmark

No account yet? Register

0
Share

European Commission Grants Marketing Authorisation for World’s First Subcutaneous Formulation of Infliximab, Remsima® SC, for an Additional Five Indications including for Use in Inflammatory Bowel Disease and Ankylosing Spondylitis

Celltrion Healthcare announced that the European Commission has granted marketing authorisation for Remsima® subcutaneous formulation for the treatment of adult patients with ankylosing spondylitis, Crohn’s disease, ulcerative colitis, psoriatic arthritis and psoriasis.
[Celltrion Healthcare ]
Press Release

Continue reading “European Commission Grants Marketing Authorisation for World’s First Subcutaneous Formulation of Infliximab, Remsima® SC, for an Additional Five Indications including for Use in Inflammatory Bowel Disease and Ankylosing Spondylitis”

Bookmark

No account yet? Register

0
Share

Henlius and Accord Healthcare Receive EMA Approval for Zercepac®, Trastuzumab Biosimilar

Shanghai Henlius Biotech, Inc. and Accord Healthcare Limited jointly announced the European Commission has approved Zercepac ® for the treatment of HER2-positive early breast cancer, HER2-positive metastatic breast cancer and HER2-positive metastatic gastric cancer.
[Henlius]
Press Release

Continue reading “Henlius and Accord Healthcare Receive EMA Approval for Zercepac®, Trastuzumab Biosimilar”

Bookmark

No account yet? Register

0
Share
Share